e-learning
resources
ERJ
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Protective role for club cell secretory protein-16 (CC16) in the development of COPD
Laucho-Contreras Maria E., Polverino Francesca, Gupta Kushagra, Taylor Katherine L., Kelly Emer, Pinto-Plata Victor, Divo Miguel, Ashfaq Naveed, Petersen Hans, Stripp Barry, Pilon Aprile L., Tesfaigzi Yohannes, Celli Bartolome R., Owen Caroline A.
Source:
Eur Respir J 2015; 45: 1544-1556
Journal Issue:
June
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Laucho-Contreras Maria E., Polverino Francesca, Gupta Kushagra, Taylor Katherine L., Kelly Emer, Pinto-Plata Victor, Divo Miguel, Ashfaq Naveed, Petersen Hans, Stripp Barry, Pilon Aprile L., Tesfaigzi Yohannes, Celli Bartolome R., Owen Caroline A.. Protective role for club cell secretory protein-16 (CC16) in the development of COPD. Eur Respir J 2015; 45: 1544-1556
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Association between serum clara cell secretory protein (CC-16) levels and asthma-related phenotypes among adults from the EGEA study
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
Neutrophil predominance phenotype in bronchial asthma. Therapeutic implication and the role of Clara cell 16-kD protein
Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation
Year: 2007
Reduced epithelial expression of secretory component and immunoglobulin-A deficiency in the bronchial mucosa in chronic bronchitis: role of tobacco?
Source: Eur Respir J 2001; 18: Suppl. 33, 520s
Year: 2001
IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013
Association between serum levels of clara cell secretory protein and lung function in adults from ECRHS
Source: Annual Congress 2012 - COPD: risk factors, biomarkers and diagnosis
Year: 2012
IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Effect of whole cigarette smoke exposure and CCSP on MUC5AC mucin production in primary cultures of human bronchial epithelial cells at air-liquid interface of COPD, smokers and control patients
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
Serum Clara cell protein (CC16), a marker of the integrity of the air-blood barrier in sarcoidosis
Source: Eur Respir J 2001; 18: 507-514
Year: 2001
Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects
Source: Eur Respir J 2002; 20: 1152-1161
Year: 2002
Loss of plasma phospholipid transfer protein (PLTP) activity enhances inflammatory responses to cigarette smoke in the lung
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013
Cigarette smoke-induced oxidative modification of creatine kinase B (CKB) is involved in the pathogenesis of COPD in terms of acceleration of bronchial epithelial cell senescence
Source: Annual Congress 2011 - Novel mechanisms in COPD
Year: 2011
Cigarette smoke augments MUC5AC mucin production via TLR3-EGFR pathway in airway epithelial cells
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
Alterations of the soluble proteome of airway epithelial cells in COPD
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
The GPx1-PTP1B-PP2A axis: A key determinant of airway inflammation and alveolar destruction
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013
Role of chronic exposure to cigarette smoke on endoglin/CD105 expression in airway epithelium
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Altered airway epithelial cell specification in COPD
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
Role of dendritic cell subsets in the early stage of cigarette smoke-induced lung inflammation
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Long-term exposure to TNF-alpha and IL-1beta reduces vitamin D-mediated expression of the antimicrobial peptide hCAP18/LL-37 in primary bronchial epithelial cells (PBEC)
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013
Reduced airway expression of cytoprotective CC10 in COPD patients and mice exposed to cigarette smoke
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Cigarette smoke alters the EZH2/DAB2IP expression in bronchial epithelial cells. A risk factor for lung cancer in COPD patients
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept